483 CBSCHEM Apr 2013

483 CBSCHEM Apr 2013

Timothy Kapsala FDA, Lisa Schultz FDA$119.00 - Available Now

FDA investigators audited the CBSCHEM - Tempe, AZ, United States facility and issued inspectional observations (via FDA 483) on 24 Apr 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Apr 2013
  • Location: Tempe, United States
  • FEI: 3009073476
Add To Cart